Current Rating and Its Significance
The 'Hold' rating assigned to Yatharth Hospital & Trauma Care Services Ltd indicates a balanced outlook for investors. It suggests that while the stock is not currently a strong buy, it is also not recommended for sale. Investors should consider maintaining their existing positions, monitoring the company’s developments closely, and evaluating market conditions before making further investment decisions.
This rating was established on 10 Apr 2026, when the company’s Mojo Score improved significantly from 48 to 65, reflecting a positive shift in its overall assessment. The Mojo Grade moved from 'Sell' to 'Hold', signalling a more stable investment profile.
Here’s How the Stock Looks Today
As of 27 May 2026, Yatharth Hospital & Trauma Care Services Ltd demonstrates a mixed but generally positive set of fundamentals. The company operates in the hospital sector and is classified as a small-cap stock. Its market capitalisation remains modest, but the recent performance metrics highlight encouraging trends.
Quality Assessment
The company holds an average quality grade, reflecting steady operational performance without significant volatility. It has maintained positive results for 11 consecutive quarters, underscoring consistent business execution. Quarterly net sales have reached a high of ₹341.56 crores, while quarterly PBDIT peaked at ₹79.91 crores, indicating robust earnings before interest, depreciation, and taxes.
Additionally, the debtors turnover ratio for the half-year stands at a healthy 3.20 times, signalling efficient receivables management. Importantly, Yatharth Hospital is net-debt free, which reduces financial risk and provides flexibility for future investments or expansions.
Valuation Considerations
Currently, the company’s valuation is considered expensive. It trades at a price-to-book value of 4.4, which is a premium compared to its peers’ historical averages. This elevated valuation reflects investor confidence but also implies limited margin for error in future earnings growth.
The return on equity (ROE) stands at 9.9%, a moderate figure that supports the current valuation but suggests room for improvement. The price-to-earnings-to-growth (PEG) ratio is 1.3, indicating that the stock’s price growth is somewhat aligned with its earnings growth, which has risen by 34.9% over the past year.
Financial Trend and Growth
The financial grade for Yatharth Hospital is positive, supported by strong top-line growth. Net sales have expanded at an annualised rate of 32.09%, reflecting healthy demand and operational scaling. Profitability has also improved, with the company delivering market-beating returns despite broader market challenges.
Over the past year, the stock has generated a remarkable 57.81% return, significantly outperforming the BSE500 index, which posted a negative return of -0.61% during the same period. Year-to-date, the stock has gained 19.02%, and over the last three months, it has appreciated by 14.33%, signalling sustained investor interest.
Technical Outlook
The technical grade for the stock is bullish, indicating positive momentum in price action. Despite a minor one-day decline of 0.52% and a one-week dip of 4.29%, the overall trend remains upward. The stock’s recent one-month gain of 8.15% and six-month increase of 5.23% reinforce this positive technical stance.
Such bullish technical indicators often attract momentum investors and can support further price appreciation, provided the company continues to deliver on its operational and financial targets.
Shareholding and Market Position
The majority of shares are held by promoters, which typically suggests a stable ownership structure and alignment of interests between management and shareholders. This can be a positive factor for long-term investors seeking governance stability.
Just announced: This Small Cap from Tyres & Allied with precise target price is our pick for the week. Get the pre-market insights that informed this selection!
- - Just announced pick
- - Pre-market insights shared
- - Tyres & Allied weekly focus
What This Rating Means for Investors
For investors, the 'Hold' rating on Yatharth Hospital & Trauma Care Services Ltd suggests a cautious but optimistic stance. The company’s solid financial trends and bullish technical outlook provide a foundation for potential growth. However, the expensive valuation and average quality grade imply that investors should carefully weigh the risks and rewards.
Maintaining current holdings while monitoring quarterly results and market developments is a prudent approach. Investors should also consider the broader healthcare sector dynamics and any regulatory changes that could impact hospital operations.
In summary, Yatharth Hospital’s current profile as of 27 May 2026 reflects a company with strong growth prospects and market-beating returns, balanced by valuation premiums and moderate quality metrics. This justifies the 'Hold' rating, signalling neither an urgent buy nor a sell recommendation but rather a position to watch closely.
Summary of Key Metrics as of 27 May 2026
- Mojo Score: 65.0 (Hold grade)
- Market Cap: Small-cap
- Net Sales Growth (Annualised): 32.09%
- ROE: 9.9%
- Price to Book Value: 4.4
- PEG Ratio: 1.3
- Stock Returns: 1 Year +57.81%, YTD +19.02%, 3 Months +14.33%
- Debt Status: Net-Debt Free
- Technical Grade: Bullish
These figures collectively provide a comprehensive view of the company’s current standing and underpin the rationale behind the 'Hold' rating.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
